<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The TrkC neurotrophin receptor belongs to the functional dependence receptor family, members of which share the ability to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the absence of their ligands </plain></SENT>
<SENT sid="1" pm="."><plain>Such a trait has been hypothesized to confer <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor activity </plain></SENT>
<SENT sid="2" pm="."><plain>Indeed, cells that express these receptors are thought to be dependent on ligand availability for their survival, a mechanism that inhibits uncontrolled <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation and migration </plain></SENT>
<SENT sid="3" pm="."><plain>TrkC is a classic tyrosine kinase receptor and therefore generally considered to be a proto-oncogene </plain></SENT>
<SENT sid="4" pm="."><plain>We show here that TrkC expression is down-regulated in a large fraction of human <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, mainly through promoter methylation </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, we show that TrkC silencing by promoter methylation is a selective advantage for colorectal cell lines to limit <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, reestablished TrkC expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines is associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> and inhibition of in vitro characteristics of cell transformation, as well as in vivo <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, we provide evidence that a mutation of TrkC detected in a <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is a loss-of-proapoptotic function mutation </plain></SENT>
<SENT sid="8" pm="."><plain>Together, these data support the conclusion that TrkC is a <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
</text></document>